Thrombotic events
Also known as: Thrombosis / Thrombus (morphologic abnormality) / Thrombotic disorder (disorder) / Thrombosis (disorder) / Thrombosis NOS / Thrombosis (qualifier value)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00054 | Abciximab | A monoclonal anti-glycoprotein IIb/IIIa receptor antibody used to prevent thrombosis during percutaneous coronary intervention. |
| DB00945 | Acetylsalicylic acid | A salicylate used to treat pain, fever, inflammation, migraines, and reducing the risk of major adverse cardiovascular events. |
| DB00278 | Argatroban | A synthetic direct thrombin inhibitor used for the prevention and treatment of thrombosis related to heparin use. |
| DB01076 | Atorvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. |
| DB00006 | Bivalirudin | A direct thrombin inhibitor used to treat heparin-induced thrombocytopenia and to prevent thrombosis during percutaneous coronary intervention. |
| DB09255 | Dextran | A low molecular weight dextran used as an adjunctive treatment of shock or impending shock due to hemorrhage, burns, surgery or other trauma, as well as the prophylaxis of venous thrombosis and pulmonary embolism during high-risk medical procedures. |
| DB00975 | Dipyridamole | A phosphodiesterase inhibitor used to prevent postoperative thromboembolic events. |
| DB00063 | Eptifibatide | A peptide-based antagonist for glycoprotein IIb/IIIa used in the medical management of myocardial infarction and as an adjunct to percutaneous coronary intervention. |
| DB00946 | Phenprocoumon | An anticoagulant drug used for the prevention of thrombosis. |